Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
A loss of -2.050% shows a downward development for Enwave Corporation.
Pros and Cons of Enwave Corporation in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -2.050% | 1.515% | -2.190% | -51.449% | -43.220% | -35.577% | -79.128% |
| Aurinia Pharmaceuticals Inc. | 1.900% | -1.371% | -5.234% | 30.731% | -3.898% | 44.961% | 33.785% |
| Spectral Medical Inc | 0.000% | 0.000% | 3.704% | 68.000% | 5.660% | 288.889% | 262.069% |
| Xenon Pharmaceuticals Inc. | -0.920% | -3.448% | 5.660% | 95.804% | 47.368% | 60.920% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
